Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 1:32 p.m.

    📋 Alaunos Therapeutics, Inc. (TCRT) - Clinical Trial Update

    Filing Date: 2026-01-08

    Accepted: 2026-01-08 08:30:24

    Event Type: Clinical Trial Update

    Event Details:

    Alaunos Therapeutics Inc (TCRT) Announces Clinical Trial Update Alaunos Therapeutics Inc (TCRT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: E. Las Olas Blvd

    🔬 Clinical Development Pipeline (Alaunos Therapeutics, Inc.):

    Product Type Development Stage Therapeutic Area Source
    Neoantigen specific TCR-T cell drug product BIOLOGICAL Phase PHASE1 Gynecologic Cancer ClinicalTrials.gov
    Aldesleukin (IL-2) BIOLOGICAL Phase PHASE1 Gynecologic Cancer ClinicalTrials.gov
    INXN-1001 DRUG Phase PHASE1 Melanoma ClinicalTrials.gov
    INXN-2001 BIOLOGICAL Phase PHASE1 Melanoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Alaunos Therapeutics Inc
    • CIK: 0001107421
    • Ticker Symbol: TCRT
    • Period End Date: 2026-01-08
    • Document Type: 8-K

Search

News categories